Trump administration to eliminate $3.6 billion annual Medicare prescription drug subsidy after 2026

The administration plans to terminate a $3.6 billion annual subsidy for Medicare prescription drug premiums starting in 2027. While officials project that 75% of policyholders will face increased costs, the administration maintains that market adjustments will mitigate the impact for the remaining quarter of beneficiaries.